0001505497 2026-08-26 2026-08-26 true 0001505497 8-K/A 2026-08-26 BIORESTORATIVE THERAPIES, INC. NV 001-37603 30-1341024 40 Marcus Drive Melville NY 11747 631 760-8100 false false false false Common Stock, par value $0.0001 per share BRTX NASDAQ false This current report on Form 8-K/A (the “Amendment”) amends and supplements the current report on Form 8-K filed by BioRestorative Therapies, Inc. (the “Company”) with the U.S. Securities and Exchange Commission (the “SEC”) on September 2, 2026 (the “Original Form 8-K”). The purpose of the Amendment is to provide additional clarifying information under Item 4.01 of the Original Form 8-K regarding (i) reportable events (within the meaning of Item 304(a)(1)(v) of Regulation S-K) discussions with CBIZ CPAs P.C., (ii) an investigation being performed by the Company’s audit committee, and (iii) the scope of the Company’s engagement of Bush & Associates CPA.  No other changes have been made to the Original Form 8-K. You should read this Amendment with the Original Form 8-K for information regarding the other items reported in the Original Form 8-K.